Chronic Kidney Disease 2007

9th International Conference on Dialysis, January 24-26, 2007, Austin, Texas

Editors

Claudio Ronco, Vicenza Nathan W. Levin, New York, N.Y.

57 figures, 6 in color, 23 tables, 2007

Basel • Freiburg • Paris • London • New York • Bangalore • Bangkok • Singapore • Tokyo • Sydney

S. Karger

Medical and Scientific Publishers Basel • Freiburg • Paris • London New York • Bangalore • Bangkok Singapore • Tokyo • Sydney

Disclaimer he statements, options and data contained in this publication are solely those of the individual authors and contributors and not of the publisher and the editor(s). he appearance of advertisements in the journal is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. he publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Drug Dosage he authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any change in indications and dosage and for added warnings and precautions. his is particularly important when the recommended agent is a new and/or infrequently employed drug.

All rights reserved.

No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center (see 'General Information').

© Copyright 2007 by S. Karger AG, P.O. Box, CH-4009 Basel (Switzerland) Printed in Switzerland on acid-free paper by Reinhardt Druck, Basel ISBN-10: 3-8055-8237-4 ISBN-13: 978-3-8055-8237-7

KARG EH

Contents

5 Preface

7 Finances of the Independent Dialysis Facility

DeOreo, P.B. (Cleveland, Ohio)

12 Dialysis and Nanotechnology: Now, 10 Years, or Never?

Fissell, W.H.; Humes, H.D. (Ann Arbor, Mich.); Fleischman, A.J.; Roy, S. (Cleveland, Ohio)

18 The Basic, Quantifiable Parameter of Dialysis Prescription Is Kt/V Urea; Treatment Time Is Determined by the Ultrafiltration Requirement: All Three Parameters Are of Equal Importance

27 Size Matters: Body Composition and Outcomes in Maintenance Hemodialysis Patients

Kotanko, P. (Graz/New York, N.Y.); Thijssen, S.; Kitzler, T.; Wystrychowski, G.; Sarkar, S.R.; Zhu, F.; Gotch, F.; Levin, N.W. (New York, N.Y.)

31 Impact ofthe Change in CMS Billing Rulesfor Erythropoietin on Hemoglobin Outcomes in Dialysis Patients

36 Guidelines for Guidelines

Amerling, R.; Winchester, J.F.; Ronco, C. (New York, N.Y./ Vicenza)

39 Diabetes: Changing the Fate of Diabetics in the Dialysis Unit

Broumand, B. (Tehran)

48 Major Difficultiesthe US Nephrologist Faces in Providing Adequate Dialysis

Diaz-Buxo, J.A.; Crawford-Bonadio, T.L. (Lexington, Mass.)

53 What Is Needed to Achieve a Hemoglobin of 11.0-13.0 g/dl in End-Stage Renal Disease

58 Vitamin C Neglect in Hemodialysis: Sailing between Scylla and Charybdis

62 Haemodialysis Fluid: Composition and Clinical Importance

Hoenich, N.A. (Newcastle upon Tyne); Ronco, C. (Vicenza)

69 Inflammation and Subclinical Infection in Chronic Kidney Disease: A Molecular Approach

Cazzavillan, S.; Ratanarat, R.; Segala, C.; Corradi, V.; de Cal, M.; Cruz, D.; Ocampo, C.; Polanco, N.; Rassu, M. (Vicenza); Levin, N. (New York, N.Y.); Ronco, C. (Vicenza)

77 Managing Complexity at Dialysis Service Centers across Europe

Stopper, A.; Amato, C.; Gioberge, S.; Giordana, G.; Marcelli, D.; Gatti, E. (Bad Homburg)

90 Treatment Time and Ultrafiltration Rate Are More Important in Dialysis Prescription than Small Molecule Clearance

99 Increasing AV Fistulae and Decreasing Dialysis Catheters: Two Aspects of Improving Patient Outcomes

103 The 2006 K/DOQI Guidelinesfor Peritoneal Dialysis Adequacy Are Not Adequate

Winchester, J.F.; Harbord, N.; Audia, P.; Dubrow, A.; Gruber, S.; Feinfeld, D.; Amerling, R. (New York, N.Y.)

106 Usefulness of a Molecular Strategy for the Detection of Bacterial DNA in Patients with Severe Sepsis Undergoing Continuous Renal Replacement Therapy

Ratanarat, R. (Vicenza/Bangkok); Cazzavillan, S. (Vicenza); Ricci, Z. (Rome); Rassu, M.; Segala, C.; de Cal, M.; Cruz, D.; Corradi, V.; Manfro, S.; Roessler, E. (Vicenza); Levin, N. (New York, N.Y.); Ronco, C. (Vicenza)

KARGER.

Access to full text and tables of contents, including tentative ones for forthcoming issues: www.karger.com/bpu_issues

112 The New KDOQI™ Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and CKD

Nelson, R.G. (Phoenix, Ariz.); Tuttle, K.R. (Spokane, Wash.) for the National Kidney Foundation

115 Coronary Artery Calcifications: A Critical Assessment of Imaging Techniques

Lembcke, A. (Berlin)

120 Practical Approaches to Management of Hyperphosphatemia: Can We Improve the Current Situation?

125 Antibodiesto Periodontal OrganismsAre Associated with Decreased Kidney Function.

The Dental Atherosclerosis Risk in Communities Study

Kshirsagar, A.V.; Offenbacher, S.; Moss, K.L.; Barros, S.P.; Beck, J.D. (Chapel Hill, N.C.)

133 Selected Pharmacokinetic Issues in Patients with Chronic Kidney Disease

Churchwell, M.D. (Toledo, Ohio); Mueller, B.A. (Ann Arbor, Mich.)

139 A Kinetic Model of Calcium Mass Balanceduring Dialysis Therapy

Gotch, F.; Kotanko, P.; Handelman, G.; Levin, N. (San Francisco, Calif.)

150 Author/Subject Index

Blood Purif 2007;25:5 DOI: 10.1159/000096890

Published online: December 14, 2006

Supplements For Diabetics

Supplements For Diabetics

All you need is a proper diet of fresh fruits and vegetables and get plenty of exercise and you'll be fine. Ever heard those words from your doctor? If that's all heshe recommends then you're missing out an important ingredient for health that he's not telling you. Fact is that you can adhere to the strictest diet, watch everything you eat and get the exercise of amarathon runner and still come down with diabetic complications. Diet, exercise and standard drug treatments simply aren't enough to help keep your diabetes under control.

Get My Free Ebook


Post a comment